Abstract:Pulmonary blastoma (PB) is a very rare subtype of sarcomatoid carcinoma with typically low-grade fetal lung adenocarcinoma (L-FLAC) and primitive mesenchymal components. Very few cases of PB contain the high-grade fetal lung adenocarcinoma (H-FLAC) component. The present study was designed to investigate the clinicopathological characteristics and the genomic heterogeneity of epithelial and mesenchymal in PB with H-FLAC. Three surgically resected PB cases with H-FLAC component were enrolled in the study. The epithelial of the first case consisted of mostly H-FLAC mixed with limited amount of L-FLAC. The other two PB tumors contained pure H-FLAC and mesenchymal components. Clinic-pathologic information and prognostic data were retrospectively reviewed. Diagnostic immunohistochemistry was performed. The epithelial and mesenchymal components were macroscopically dissected to profile the genetic alterations separately using capture-based targeted sequencing. A commercialized panel, consisting of 520 cancer-related genes, was used. The cells of H-FLAC components in PB showed obvious atypia with more necrosis and enteric adenocarcinoma-like morphology. The squamoid morules were absent in H-FLAC. Proliferation index of the H-FLAC components (30%-80%) was higher than that of the mesenchymal (15%-20%). No aberrant nuclear expression of β-catenin protein and missense mutation in exon 3 of CTNNB1 gene were observed in H-FLAC and all mesenchymal cells. Within a tumor, epithelial and mesenchymal components exhibited relatively comparable molecular profile. In patient 1, 4 mutations: PB1, FAT3, PTCH1 and LRP1B were shared by both epithelial and mesenchymal components. Epithelial component had additional mutations in BCOR, CTNNB1, CTCF, FAT1 and DICER1. In patient 2, 12 mutations were shared. The epithelial component had BRCA2 mutations and the mesenchymal component had mutations in CREBBP, ALK, DNMT3A, ASXL2, MYCN and RICTOR. Patient 3 had 6 shared mutations. The epithelial component had an additional mutation in KAT6A and the mesenchymal had an additional mutation in APC. Furthermore, both epithelial and mesenchymal components showed significant interpersonal heterogeneity. In other words, the mutation spectrum of the same component (epithelial or mesenchymal) varies significantly among patients. Surprisingly, not a single common mutation was found in the same component among the 3 patients. Collectively, we observed heterogeneity between epithelial and mesenchymal components of the same tumor. In addition, we also observed significant inter-personal heterogeneity of the same component among different patients. Parallel detection of genetic abnormalities in epithelial and mesenchymal could provide further evidence to clarify the histopathological difference and molecular heterogeneity in pulmonary blastoma.

Fetal lung adenocarcinoma-low grade: a clinicopathological study of 3 cases

Differences Between Low and High Grade Fetal Adenocarcinoma of the Lung: a Clinicopathological and Molecular Study

Coexistence of Low-Grade Fetal Adenocarcinoma and Adenocarcinoma in Situ of the Lung Harboring Different Genetic Mutations: A Case Report and Review of Literature

Clinical and Pathological Characteristics and Prognosis of Lung Adenocarcinoma With High-Grade Fetal Features: A Retrospective Analysis

Cytomorphology of pulmonary low‐grade fetal adenocarcinoma in bronchial brushing specimen prepared by BD SurePath: A case report and literature review

A case report of high-grade fetal lung adenocarcinoma with KRAS mutation

P1.09-31 Clinicopathological Features and Genomic Profiling of Pulmonary Blastoma with High-Grade Fetal Adenocarcinoma Component

Abstract 112: Multi-omics analysis of molecular landscape and heterogeneity in fetal adenocarcinoma of the lung

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

[Surgical Resection of High-grade Fetal Adenocarcinoma of the Lung:Report of a Case]

[Anaplastic Lymphoma Kinase-Positive Adenocarcinoma of Lung: a Cytopathologic Analysis].

Gene Status and Clinicopathologic Characteristics of Lung Adeno-Carcinomas with Mediastinal Lymph Node Metastasis

Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma

Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype

Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review

Clinical Characteristics and Progression of Pre-/Minimally Invasive Lung Adenocarcinoma Harboring ALK or RET Rearrangements: a Retrospective Cohort Study.

Analysis of Mutational and Clinicopathologic Characteristics of Lung Adenocarcinoma with Clear Cell Component.

P1.09-18 15 Cases of Clinical and Molecular Features Analysis in Pulmonary Adenoid Cystic Carcinoma

Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

[Clinicopathologic study of pulmonary adenocarcinoma with features of bronchioloalveolar carcinoma]